Table 2 Distribution of the APOE, SCARB1, PPARα genotypes and frequency of the alleles (%) in the study population
Characteristics | Men | Women | p value |
|---|---|---|---|
n (%) | n (%) | ||
APOE, | n.s. | ||
ϵ 2/2 genotype | 2 (0.5) | 2 (0.3) | |
ϵ 3/2 genotype | 76 (17.9) | 94 (15.7) | |
ϵ 3/3 genotype | 270 (63.6) | 359 (59.7) | |
ϵ 4/2 genotype | 13 (3.0) | 21 (3.5) | |
ϵ 4/3 genotype | 61 (14.5) | 116 (19.3) | |
ϵ 4/4 genotype | 2 (0.5) | 9 (1.5) | |
ϵ3 allele | 79.8 | 77.2 | n.s. |
ϵ2 allele | 11.0 | 9.9 | |
ϵ4 allele | 9.2 | 12.9 | |
SCARB1, | n.s. | ||
CC genotype | 149 (35.2) | 215 (35.8) | |
CT genotype | 212 (50,0) | 287 (47.8) | |
TT genotype | 63 (14.8) | 99 (16.4) | |
C allele | 58.9 | 58.4 | n.s. |
T allele | 41.1 | 41.6 | |
PPARα, | n.s. | ||
CC genotype | 399 (94.2) | 568 (94.5) | |
CG genotype | 25 (5.8) | 32 (5.3) | |
GG genotype | 0 | 1(0.2) | |
C allele | 97.1 | 97.3 | n.s. |
G allele | 2.90 | 2.70 |